IDEX Health & Science

Welcome, Guest: Login or Register  |  My Cart

February 2015

IDEX Health & Science Announces Market Segmentation

By Heidi Lechner February 19, 2015

PRESS RELEASE
FOR IMMEDIATE RELEASE

For further information, please contact:
Robin Fischer
Tel: +1 360 682 4247
E-mail: rfischer@idexcorp.com

Featuring two businesses: Analytical Instruments and In Vitro Diagnostics / Biotechnology

ROHNERT PARK, CA, February 13, 2015 — IDEX Health & Science, LLC (IH&S), a division of IDEX Corporation’s (NYSE:IEX) Health & Science Technologies, announces its segmentation into two distinct businesses: Analytical Instruments and In Vitro Diagnostics / Biotechnology. The structural realignment of IDEX Health & Science into two market-specific sectors will drive growth and better serve customers in their respective end-markets.

Greg Orr has been named VP/GM of the Analytical Instrument (AI) business. This sector will combine global research & development, engineering, and commercial resources to focus on new OEM platforms and consumable/aftermarket products. The Analytical Instruments business will serve the non-clinical analytical instrument market.

Joe Rytell has been appointed VP/GM of the In Vitro Diagnostics and Biotech (IVD/Biotech) business. This sector will combine global research & development, engineering, and commercial resources to focus on IVD core-lab, next generation DNA sequencing, molecular diagnostics, and professional point-of-care. The IVD/Biotech business will organize IH&S activity into one group that serves clinical OEM instrumentation manufacturers.

IDEX Health & Science manufacturing has also been realigned with a focus on operational excellence in producing products for these markets. Keith Andrews has been named Regional Operations Director for the Rohnert Park and Oak Harbor sites. Chad Collins has also been named Regional Operations Director and will manage the Middleboro and Bristol facilities. Yoshio Ishii will continue to provide leadership to the ERC site in Saitama, Japan.

This newly announced business segmentation is intended to accelerate product innovation, better

leverage the full suite of IDEX Health & Science products and technology, and enhance the overall customer experience as a result of dedicated, market-focused teams and simplified reporting structures.

Recent Posts
Archives

 

Subscribe to Our
News Bulletin

 

Custom Path

Partner with IDEX Health & Science on the optimization and validation of your fluidic pathway.

Our Catalogs

Get our new Optofluidics Catalog. Browse our fluidic and optical products and explore our pathway capabilities.

Contact Us

Locate a Distributor or Contact Us, or find us on social media:

https://www.facebook.com/idexhealth/  LinkedIn  YouTube  Twitter